Brain injury and inflammation. A putative role of TNF alpha.
D000818:Animals; D001930:Brain Injuries / Q000503:physiopathology* / Q000517:prevention & control; D002118:Calcium / Q000378:metabolism; D002448:Cell Adhesion; D015815:Cell Adhesion Molecules / Q000502:physiology; D016923:Cell Death / Q000187:drug effects; D002490:Central Nervous System / Q000378:metabolism / Q000502:physiology; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000503:physiopathology*; D007962:Leukocytes / Q000502:physiology; D009281:Naphthalenes / Q000627:therapeutic use; D009474:Neurons / Q000187:drug effects / Q000473:pathology; D009498:Neurotoxins / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011760:Pyrrolidinones / Q000627:therapeutic use; D020889:Rolipram; D014158:Transcription, Genetic / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*
D015815:Cell Adhesion Molecules; D004791:Enzyme Inhibitors; D009281:Naphthalenes; D009498:Neurotoxins; D010726:Phosphodiesterase Inhibitors; D011500:Protein Synthesis Inhibitors; D011760:Pyrrolidinones; D014409:Tumor Necrosis Factor-alpha; C061465:calphostin complex; D011493:Protein Kinase C; D020889:Rolipram; D002118:Calcium